Fremanezumab treatment reduces headache severity and durations for patients with chronic migraine or episodic migraine, according to new findings presented at the American Academy of Neurology Annual Meeting.
Fremanezumab treatment reduces headache severity and durations for patients with chronic migraine or episodic migraine, according to new findings presented at the American Academy of Neurology Annual Meeting.
Fremanezumab treatment reduces...